Edgewise Therapeutics Inc
(NAS:EWTX)
$
39.58
+0.78 (+2%)
Market Cap: 4.26 Bil
Enterprise Value: 3.76 Bil
PE Ratio: 0
PB Ratio: 8.62
GF Score: 28/100 
Edgewise Therapeutics Inc at RBC Capital Markets Global Healthcare Conference Transcript
May 20, 2026 / 02:00PM GMT
Release Date Price:
$32.82
(+4.42%)
Unidentified_3
All right. Thanks, everyone, for being here. For our next session, we've got Edgewise represented by Kevin, their CEO; and Behrad, their Chief Operating Officer. So thanks for being here.
Kevin Koch
Edgewise Therapeutics Inc - President, Chief Executive Officer, Director
Thank you. It was great.
Behrad Derakhshan
Edgewise Therapeutics Inc - Chief Operating Officer
Good to see you.
Kevin Koch
Edgewise Therapeutics Inc - President, Chief Executive Officer, Director
Good to see you.
Questions & Answers
Unidentified_3;Kevin Koch
Edgewise Therapeutics Inc - President, Chief
So there's a lot of things going on with the company, but I figured I'd start with the HCM side of the business. Maybe just to help set the stage, you've got pretty unique molecule in 7,500. Can you talk about what you think may be the key advantages of 7,500 versus some of the other modalities that are out there?
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers